World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
46050
World Ranking
8791
National Ranking
46

Overview

Horst Olschewski is affiliated with the Medical University of Graz in Austria. Their research primarily focuses on the medical field, with a substantial number of publications in pulmonary and respiratory medicine, cardiology and cardiovascular medicine, molecular biology, epidemiology, and physiology.

The main topics of Horst Olschewski's work include:

  • Pulmonary Hypertension Research and Treatments
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Cardiovascular Function and Risk Factors
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Respiratory Support and Mechanisms
  • Heart Failure Treatment and Management
  • Congenital Heart Disease Studies

Frequent co-authors in their publications are:

  • Gábor Kovács
  • Vasile Foris
  • Katarina Zeder
  • Andrea Olschewski
  • Philipp Douschan

Their research has been published in various academic journals, with multiple papers appearing in:

  • American Journal of Respiratory and Critical Care Medicine
  • European Respiratory Journal
  • Pulmonary Circulation
  • Wiener klinische Wochenschrift
  • CHEST Journal

Some recent papers authored or co-authored by Horst Olschewski include:

  • 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, 2022, European Heart Journal
  • Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study, 2020, The Lancet Respiratory Medicine
  • Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances, 2021, American Journal of Respiratory and Critical Care Medicine
  • Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial, 2021, The Lancet Respiratory Medicine
  • Between inflammation and thrombosis: endothelial cells in COVID-19, 2021, European Respiratory Journal

Best Publications

  • Updated clinical classification of pulmonary hypertension

    Gerald Simonneau;Michael A Gatzoulis;Ian Adatia;David Celermajer

  • Inhaled iloprost for severe pulmonary hypertension.

    Horst Olschewski;Gerald Simonneau;Nazzareno Galiè;Timothy Higenbottam

  • Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.

    Nazzareno Galiè;Adam Torbicki;Robyn Barst;Philippe Dartevelle

  • Diagnosis and Assessment of Pulmonary Arterial Hypertension

    David B. Badesch;Hunter C. Champion;Miguel Angel Gomez Sanchez;Marius M. Hoeper

  • Diagnosis and differential assessment of pulmonary arterial hypertension

    Robyn J Barst;Michael McGoon;Adam Torbicki;Olivier Sitbon

  • Ambrisentan for the Treatment of Pulmonary Arterial Hypertension Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2

    Nazzareno Galiè;Horst Olschewski;Ronald J. Oudiz;Fernando Torres

  • Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review

    G Kovacs;A Berghold;S Scheidl;H Olschewski

  • Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

    Hossein Ardeschir Ghofrani;Ralph Wiedemann;Frank Rose;Ralph T Schermuly

  • Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension

    Derliz Mereles;Nicola Ehlken;Sandra Kreuscher;Stefanie Ghofrani

  • Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy.

    Richard Schulz;Siamak Mahmoudi;Katja Hattar;Ulf Sibelius

  • Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension

    Hossein Ardeschir Ghofrani;Ralph Wiedemann;Frank Rose;Horst Olschewski

  • Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension: A Randomized Controlled Clinical Trial

    Vallerie V. McLaughlin;Raymond L. Benza;Lewis J. Rubin;Richard N. Channick

  • Ambrisentan Therapy for Pulmonary Arterial Hypertension

    Nazzareno Galié;David Badesch;Ronald Oudiz;Gérald Simonneau

  • Pulmonary hypertension in chronic lung disease and hypoxia.

    Steven D. Nathan;Joan A. Barbera;Sean P. Gaine;Sergio Harari

  • Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.

    Rajiv D. Machado;Micheala A. Aldred;Victoria James;Rachel E. Harrison

  • Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.

    Horst Olschewski;Dieter Walmrath;Ralph Schermuly;H. Ardeshir Ghofrani

  • Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension

    Marius M. Hoeper;Joan Albert Barberà;Richard N. Channick;Paul M. Hassoun

  • Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

    Hossein A Ghofrani;Frank Rose;Ralph T Schermuly;Horst Olschewski

  • Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis

    Horst Olschewski;H. Ardeschir Ghofrani;Dieter Walmrath;Ralph Schermuly

  • Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome.

    Dieter Walmrath;Thomas Schneider;Ralph Schermuly;Horst Olschewski

Frequent Co-Authors

Werner Seeger
Werner Seeger University of Giessen
Hossein Ardeschir Ghofrani
Hossein Ardeschir Ghofrani University of Giessen
Marius M. Hoeper
Marius M. Hoeper Hannover Medical School
Gabor G. Kovacs
Gabor G. Kovacs University of Toronto
Friedrich Grimminger
Friedrich Grimminger University of Giessen
Ralph T. Schermuly
Ralph T. Schermuly University of Giessen
Walter Klepetko
Walter Klepetko Medical University of Vienna
Stephan Rosenkranz
Stephan Rosenkranz University of Cologne
Norbert Weissmann
Norbert Weissmann University of Giessen
Martin Urschler
Martin Urschler University of Auckland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in healthcare but want flexible or alternative pathways to becoming a doctor, there are several online degrees and careers to consider. Many choose to start with adn nursing programs, which are often more accessible than traditional medical degrees and lead to fulfilling roles as registered nurses.

Another growing field is medical billing and coding. Students worried about the cost of education can explore financial aid for medical billing and coding online classes, making this a budget-friendly entry into healthcare administration.

If standardized testing is a concern, research if do all nursing schools require the teas exam. Many nursing schools now offer admission without these entrance tests, opening up more opportunities for prospective students.

For those seeking management roles, earning a degree in healthcare administration online can fast-track your career. These programs offer accelerated and flexible options to advance in the business side of healthcare.

Best Scientists Citing Horst Olschewski

Trending Scientists

Recently Published Articles